Market Cap: $291.62M
AI
Arcturus Therapeutics Holdings Inc.
ARCT
NASDAQ (NASDAQ Global Market)USD
Market Cap: $291.62M
Arcturus Therapeutics Holdings (NASDAQ: ARCT) is a San Diego-based clinical-stage mRNA company built around two proprietary technologies: the LUNAR lipid-mediated delivery platform and STARR self-ampl…
Arcturus Therapeutics: Reinventing mRNA Innovation Arcturus Therapeutics Holdings, a key player in the rapidly evolving biopharmaceutical landscape, exhibits remarkable momentum as it reports a 25% ye…
Anticipation Builds for Arcturus Therapeutics’ Quarterly Earnings Report With March 3, 2026, on the horizon, Arcturus Therapeutics Holdings finds itself in a crucial phase as it prepares to unveil its…
Anticipating Earnings: A Pivotal Moment for Arcturus Therapeutics Arcturus Therapeutics Holdings, a prominent player in the biopharmaceutical sector, prepares to unveil its quarterly earnings report o…
Arcturus Therapeutics Prepares for Key Earnings Announcement Amidst Pipeline Developments Arcturus Therapeutics, a prominent player in the biopharmaceutical industry, gears up for the release of its q…
Arcturus Therapeutics: Advancements in mRNA Therapeutics Amidst Industry Developments Arcturus Therapeutics Holdings is positioned at the forefront of the rapidly evolving mRNA therapeutics sector, ca…
Arcturus Therapeutics: Pioneering mRNA Therapeutics in a Competitive Landscape Arcturus Therapeutics Holdings is positioning itself as a leader in the rapidly evolving field of mRNA therapeutics. The…
Arcturus Therapeutics: Pioneering mRNA Therapeutics Ahead of Earnings Call Arcturus Therapeutics Holdings prepares for its quarterly earnings announcement on November 10, 2025, a key event that invest…
Arcturus Therapeutics Gears Up for Quarterly Earnings: Focus on mRNA Innovations As Arcturus Therapeutics prepares for its quarterly earnings announcement on November 10, 2025, the biopharmaceutical c…
Arcturus Therapeutics Advances mRNA Therapy for Cystic Fibrosis Amid Mixed Market Reception Arcturus Therapeutics Holdings Inc. is currently navigating the complexities of its Phase 2 clinical trial f…
Arcturus Therapeutics Advances mRNA Therapy Amid Market Uncertainty Arcturus Therapeutics Holdings Inc. is at a pivotal moment in its development of ARCT-032, an inhaled mRNA therapy targeting cystic…
Arcturus Therapeutics Holdings: Pioneering mRNA Therapeutics Amid Market Shifts In a landscape marked by rapid advancements in biotechnology, Arcturus Therapeutics Holdings stands out with its innovat…
Arcturus Therapeutics Advances mRNA Vaccine Development Arcturus Therapeutics Holdings, a biotechnology company focusing on messenger RNA (mRNA) therapeutics, is making significant strides in the deve…
Arcturus Therapeutics Faces Mixed Analyst Opinions Amidst Innovation and Challenges In recent days, Arcturus Therapeutics (ARCT) captures the attention of market analysts as they assess the company's…
Innovative Manufacturing for COVID-19 Vaccines: A Joint Venture's Impact on Japanese Pharmaceutical Production Recent developments in the Japanese pharmaceutical landscape highlight the significance o…
Arcturus Therapeutics Showcases mRNA Innovations at Biotech Conference Arcturus Therapeutics Holdings Inc., a pioneering messenger RNA (mRNA) medicines company based in San Diego, announces its partic…
Arcturus Therapeutics Advances mRNA Vaccine Manufacturing Through Strategic Collaboration Arcturus Therapeutics Holdings Inc., a pioneering company in the field of messenger RNA (mRNA) medicines, is c…
Arcturus Therapeutics: Pioneering the Future of mRNA Medicine Arcturus Therapeutics Holdings Inc., based in San Diego and founded in 2013, is at the forefront of developing messenger RNA (mRNA) therap…
Arcturus Therapeutics Advances mRNA Technology in Infectious Disease and Rare Disorders Arcturus Therapeutics Holdings Inc., a pioneer in the field of messenger RNA (mRNA) medicines, is at the forefro…
Arcturus Therapeutics: Advancing mRNA Medicine for Infectious and Rare Diseases Arcturus Therapeutics Holdings Inc., a pioneering entity in the messenger RNA (mRNA) medicine landscape, continues to so…
Arcturus Therapeutics: Expanding Horizons in mRNA Medicine Arcturus Therapeutics Holdings Inc., a prominent player in the messenger RNA (mRNA) medicine landscape, is poised to showcase its innovative…
Arcturus Therapeutics Advances Pandemic Preparedness with New Vaccine Candidate Arcturus Therapeutics Holdings Inc., a San Diego-based biotechnology firm, announces a significant milestone in its miss…